We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$10.8B
AUM Growth
-$4.51B
Cap. Flow
-$5.9B
Cap. Flow %
-54.51%
Top 10 Hldgs %
36.37%
Holding
2,157
New
513
Increased
320
Reduced
516
Closed
607

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$126M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$56.9M
3
ARGX icon
argenx
ARGX
+$51.2M
4
DAL icon
Delta Air Lines
DAL
+$47.9M
5
GLNG icon
Golar LNG
GLNG
+$41.7M

Sector Composition

Rank Sector Weight
1 Healthcare 8.36%
2 Technology 4.71%
3 Industrials 4.28%
4 Financials 3.27%
5 Energy 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYCR
1976
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-730,000
Closed -$15.8M
ITCI
1977
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-2,000
Closed -$143K
ITCI
1978
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-29,000
Closed -$2.08M
ITCI
1979
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-500
Closed -$35.8K
EDR
1980
DELISTED
Endeavor Group Holdings, Inc.
EDR
-67,659
Closed -$1.66M
AZPN
1981
DELISTED
Aspen Technology Inc
AZPN
-954
Closed -$210K
NKGNW
1982
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
-35,000
Closed -$2.83K
INFN
1983
DELISTED
Infinera Corporation Common Stock
INFN
-13,484
Closed -$64K
RVNC
1984
DELISTED
Revance Therapeutics, Inc.
RVNC
-29,971
Closed -$263K
RVNC
1985
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
-23,000
Closed -$202K
HTLF
1986
DELISTED
Heartland Financial USA, Inc.
HTLF
-12,500
Closed -$470K
RGF
1987
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
-5,325
Closed -$97.1K
TCS
1988
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
-2,987
Closed -$102K
RCM
1989
DELISTED
R1 RCM Inc. Common Stock
RCM
-13,287
Closed -$140K
AXNX
1990
DELISTED
Axonics, Inc. Common Stock
AXNX
-4,210
Closed -$262K
ME
1991
DELISTED
23andMe Holding Co
ME
-3,126
Closed -$57.1K
EGRX
1992
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-118,857
Closed -$622K
EGIO
1993
DELISTED
Edgio, Inc. Common Stock
EGIO
-2,500
Closed -$34.3K
AIRC
1994
DELISTED
Apartment Income REIT Corp.
AIRC
-14,819
Closed -$515K
TDCX
1995
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
-200,000
Closed -$970K
MRNS
1996
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-50,000
Closed -$544K
ZFOX
1997
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
-349,941
Closed -$304K
PGTI
1998
DELISTED
PGT, Inc.
PGTI
-28,000
Closed -$1.14M
FSR
1999
DELISTED
Fisker Inc.
FSR
-150,000
Closed -$263K
FSR
2000
PUT
DELISTED
Fisker Inc.
FSR
-450,000
Closed -$788K

Similar funds

Jefferies Financial Group's Q1 2024 Portfolio in Review

As of Q1 2024, Jefferies Financial Group held 2,157 positions worth $10.8B, down 29% from $15.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jefferies Financial Group withdrew a net $5.9B in Q1 2024, closing 607 positions and reducing 516 holdings. Its most notable exit was Surgery Partners, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, up from 6.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Financial Group opened a new position in Golar LNG worth $45M.

  • Jefferies Financial Group's largest Q1 2024 buy was Golar LNG: 1,872,202 shares worth $45M.
  • Jefferies Financial Group added most to Visa in Q1 2024, an estimated $126M increase.
  • Jefferies Financial Group's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $962M.
  • Jefferies Financial Group fully exited Surgery Partners in Q1 2024, selling an estimated $146M.
  • Jefferies Financial Group's ten largest holdings make up 36% of its $10.8B portfolio in Q1 2024.
  • Jefferies Financial Group opened 513 new positions and closed 607 in Q1 2024.
  • Jefferies Financial Group's portfolio value fell 29% quarter-over-quarter to $10.8B.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.